Lead party: The African Development Bank Group (AfDB) (lead investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: The Biologicals and Vaccines Institute of Southern Africa Proprietary Limited (private company) · Sector: Healthcare, Pharmaceuticals, Biotechnology · Countries of operation: Mozambique, Lesotho, Angola, Namibia, South Africa, Botswana, Eswatini
Transaction type: Debt Financing · Asset class: Private Credit · Strategy: Direct Lending · Instrument: Private Capital (Debt) · Deal amount: US$15m
Lead investor/buyer: The African Development Bank Group (AfDB) · Investors/buyers: The African Development Bank Group (AfDB)
Legal advisers: not identified in the source record.
Source: announced 5 August 2026. Original announcement: empowerafrica.com.


